Abstract:Purpose: The objective of this study was to elucidate the spectrum of brain natriuretic peptide (BNP) expression in hemodialysis patients with euvolemic status and investigate its prognostic significance. Methods: Patients on chronic hemodialysis were enrolled. The normal range of BNP was measured and analyzed in patients with euvolemic status defined by systolic blood pressure and overhydration. Hemodialysis patients were stratified into groups according to BNP expression at baseline and followed up for 57 months, with all-cause mortality and cardiovascular disease-related death being assessed as primary outcomes. Results: BNP significantly correlated with overhydration in all patients (r = 0.255, P = .004). In patients with euvolemic state, the average BNP level was 701 (±645) pg/ml, with a 95% confidence interval (CI) of 500-902 pg/ml. In patients with BNP < 902 pg/ml, systolic blood pressure significantly correlated with overhydration. Elevated BNP expression correlated with an increased risk of cardiovascular mortality (HR = 1.871, per 782 pg/ml increase, P = .008). The patients with continuously high levels of BNP showed significantly increased risk of cardiovascular disease-related death during follow-up (HR = 12.845, P = .005). Conclusion: Predialysis measured BNP levels correlate with volume status, and the common range is from 500 to 902 pg/ml in dialysis patients with euvolemic status. Patients with upregulated BNP expression showed an increased risk of cardiovascular death. Key messages What is already known on this topic The volume management of hemodialysis patients should be judged comprehensively by clinical manifestations and objective examinations. The parameters involved in the evaluation need to be further optimized. What this study adds In hemodialysis patients, BNP serves as an indicator of volume status. Properly hydrated hemodialysis patients typically exhibit BNP levels ranging from 500 to 902 pg/ml, while persistent BNP elevation is associated with increased mortality. How this study might affect research, practice, or policy In clinical practice, BNP can be routinely monitored in hemodialysis patients to provide information for volume adjustment and to identify patients with high mortality risk. The potential advantages of implementing targeted BNP management warrant further investigation through intervention studies.

Clinical Research about the Relation Between B-type Natriuretic Peptide Level and the Dry Weight of Maintenance Hemodialysis Patients

Correlation Between B Type Natriuretic Peptide And Metabolic Risk Factors

Significance of Dynamic Change of Plasma ANP and BNP Levels in Patients on Maintenance Hemodialysis

Correlation analysis of N-terminal pro-brain natriuretic peptide in maintenance hemodialysis patients

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Clinical Research of Relationship Between N-terminal Pro-Brain Natriuretic Peptide Levels and Cardiovascular Events in Maintenance Hemodialysis Patients

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Brain natriuretic peptide reflects volume status and influences on survival of hemodialysis patients

Plasma NT-proBNP Levels Can Predict Cardiac Load in Patients on Maintainence Hemodialysis

Cross-sectional Study of NT-pro Brain Natriuretic Peptide and Its Correlation with Heart Remodeling and Function in Maintenance Hemodialysis Patients

Relationship of Serum Amino-Terminal Pro-B-natriuretic Peptide with Cardiovascular Disease and Malnutrition in Patients with Maintenance Hemodialysis

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients

Variation of brain natriuretic peptide assists with volume management and predicts prognosis of hemodialysis patients

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Changes in Brain Natriuretic Peptide Are Correlated with Changes in Global End-Diastolic Volume Index

B-type Natriuretic Peptide Levels and Volume Status in Twice-Weekly Hemodialysis Patients

Relationships among pulmonary capillary wedge pressure, dry weight and natriuretic peptide in patients undergoing hemodialysis: a three-dimensional speckle tracking echocardiography study

B type natriuretic peptide apply for dignosis and treatment in patients with congestive heart failure

Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction

Pathophysiology and significance of natriuretic peptides in patients with end-stage kidney disease

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure